Stock Yearly Return 2021
Start date: 01/04/2021
End date: 12/31/2021
Start price/share: $2.81
End price/share: $1.00
Dividends collected/share: $0.00
Total return: -64.41%
PHIO Average Annual Return: -65.13%
Starting investment: $10,000.00
Ending investment: $3,559.00
Years: 0.99


PHIO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare PHIO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into PHIO


Also see:
PHIO YTD return
PHIO average annual return 10 years
Phio Pharmaceuticals is a biotechnology company developing immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA®) therapeutic platform. Co. is focused on its proprietary INTASYL™ platform with utility in immune cells and/or the tumor micro-environment. Co. has two product candidates that are being developed for use in Adoptive Cell Transfer, PH-762 and PH-804. Co.'s primary pipeline compound, PH-762, targets the checkpoint protein PD-1, a checkpoint protein on immune cells. Co.'s second pipeline compound, PH-804, targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells. The PHIO stock yearly return is shown above.

The yearly return on the PHIO stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2021 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the PHIO annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree PHIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Phio Pharmaceuticals (PHIO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

PIRS Average Annual Return
PKI Average Annual Return
PLRX Average Annual Return
PLSE Average Annual Return
PLXP Average Annual Return
PMCB Average Annual Return
PMD Average Annual Return
PMVP Average Annual Return
POAI Average Annual Return
PODD Average Annual Return
More Healthcare companies »

 

PHIO Stock Yearly Return 2021 | www.AverageAnnualReturn.com | Copyright © 2021 - 2022, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.